(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
The Sunshine Vitamin: What, Where, and How Much?

The Sunshine Vitamin: What, Where, and How Much?

by Carley Lovnicki | Nov 17, 2020 | Natural Health Products, Our View, Research/Science/Technology

When the majority of people hear the term Vitamin D, they will immediately associate it with images of sunshine, warm climates, and the summer season. That is to say, many people are aware of the essential vitamin and our primary source of obtaining it, but: what...
A Risk-Based Approach to Site License Applications

A Risk-Based Approach to Site License Applications

by Carley Lovnicki | Nov 13, 2020 | Canadian Regulatory, Natural Health Products

In attempt to eliminate the recent issue of site license renewal backlogs, the Natural and Non-Prescription Health Products Directorate (NNHPD) is implementing a new risk based approach to the site license application. With an ambitious goal of removing all backlog by...
COVID-19 and Vitamin D: Correlation or Coincidence?

COVID-19 and Vitamin D: Correlation or Coincidence?

by Carley Lovnicki | Nov 3, 2020 | Canadian Regulatory, Research/Science/Technology

The past several months have unquestionably been inundated with what sometimes feels like constant streams of new information and theories surrounding the global virus, COVID-19. Some of the most thought-provoking of which concern a potential correlation between...
New Canadian Cosmetic Ingredient Hotlist Updates

New Canadian Cosmetic Ingredient Hotlist Updates

by Carley Lovnicki | Oct 22, 2020 | Canadian Regulatory, Cosmetics

Earlier this month, Health Canada released a new list of proposed updates to the Cosmetic Ingredient Hotlist, which included new additions, as well as revisions, to both the restricted and prohibited cosmetic ingredient lists. The proposed new additions to the...
New Cosmetic Ingredient Restrictions in the State of California

New Cosmetic Ingredient Restrictions in the State of California

by Carley Lovnicki | Oct 9, 2020 | Cosmetics, U.S. Regulatory

This month two new bills were signed by the Governor of California, implementing new restrictions on cosmetic ingredients within the state. The first of these bills, titled AB-2762 (Cosmetic Products: Safety), includes a list of twelve substances, including Dibutyl...

Recent Posts

  • Interferon Beta 1a: Potentially Promising Treatment for Covid-19
  • The Sunshine Vitamin: What, Where, and How Much?
  • A Risk-Based Approach to Site License Applications
  • COVID-19 and Vitamin D: Correlation or Coincidence?
  • New Canadian Cosmetic Ingredient Hotlist Updates

Recent Comments

    Archives

    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2020 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     


    Jennifer Porter

    Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

    Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.